✦ LIBER ✦

Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus

✍ Scribed by V.A. Fonseca; D.E. Kelley; W. Cefalu; M.A. Baron; D. Purkayastha; J.E. Nestler; S. Hsia; J.E. Gerich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to “Hypoglycemic potential of na

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Nateglinide versus repaglinide for type

✍ Chanjuan Li; Jielai Xia; Gaokui Zhang; Suzhen Wang; Ling Wang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 207 KB

Long-term Safety of Pioglitazone versus

✍ Dr. Rajeev Jain; Dr. Kwame Osei; Dr. Stuart Kupfer; Dr. Alfonso T. Perez; Mr. Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Nateglinide provides tighter glycaemic c

✍ A. Bellomo Damato; G. Stefanelli; L. Laviola; R. Giorgino; F. Giorgino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Nateglinide – current and future role in

✍ I. W. Campbell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Beneficial metabolic effects of nateglin

✍ Hong-wei GAO; Chao XIE; Hai-ning WANG; Yu-jing LIN; Tian-pei HONG 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 Chinese ⚖ 262 KB